chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heavy chested; Shortness of breath/ it's uncomfortable to breathe a little bit with the chest; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE), dose 2 at vaccination age of 40-year-old via an unspecified route of administration in the left arm on 08Apr2021 13:30-14:00 (Lot Number: ER8737; Expiration Date: Jul2021) as 2nd dose, single dose for covid-19 immunization. The patient medical history and family history were none. The patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE) in the left arm on 18Mar2021 at 09:00 (lot number: EP7534) at vaccination age of 40-year-old as 1st dose, single dose for covid-19 immunization. The patient's concomitant medications were not reported. The patient did not receive other vaccine on the same day with the Pfizer Covid-19 vaccine. The patient did not receive other vaccinations within four weeks prior to the administration of the Pfizer Covid-19 vaccine. The patient mentioned that she got her second vaccine on 08Apr2021 and by that Sunday (11Apr2021), that past weekend, she began to feel heavy chested and since that date it has been off and on with heavy chest and a little bit of shortness of breath. The patient reported that she went to the doctor today (27May2021) for it, they did an x-ray of her heart an EKG and some blood work and she is just waiting for all that to come back (pending results). She reported further that heavy chested lasted a few days then it subsided, it does not necessarily go all the way away. She stated she randomly gets heavy chested and short of breath, she cannot pinpoint why or how, it just happens. She finally made a doctor's appointment because she has the worst case of it Monday (25May2021) and Tuesday (26May2021) and it was not going away. Her chest was so tight and heavy, and she was having shortness of breath. It usually subsides within the day and the following day, she will feel better but on Monday and on Tuesday, it was persistent and she had no relief until Wednesday and even then, it was not 100% relieved. She confirmed that the shortness of breath started around the same time. The patient mentioned that it is uncomfortable to breathe a little bit with the chest. The reporter states it's not all the time, but it did worsen Monday and Tuesday. The patient confirms both the heavy chested and shortness of breath have worsened. The adverse events did not result an emergence room visit but she was close since she did not want to go in there because there is COVID patients there. The adverse events though resulted in a physician office visit. The patient underwent lab tests and procedures which included blood work, x-ray of heart and EKG performed on 27May2021 with pending results. The outcome of the events was not recovered.   The following information on the batch/lot number has been requested.
This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history lyme disease and known allergies to Bivalve. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lyme disease vaccine (LYME), vitamin d nos (VIT D), retinol (VITAMIN A), ascorbic acid (VIT C), calcium (BUFFER C) and naltrexone (NALTREXONE), rhamnus cathartica/ rhamnus purshiana/ senna spp. (HERBAL), all for an unknown indication from an unknown dates and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 16:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 05May2021, the patient experienced fatigue (Gr3), chills (Gr1), muscle aches (Gr2), headache (Gr1), nausea (Gr1), intestinal discomfort (Gr2). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fatigue (Gr3), chills (Gr1), muscle aches (Gr2), headache (Gr1), nausea (Gr1), intestinal discomfort (Gr2) was recovered on an unknown date in May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Per moms report, 103 fever and speech regression. mom states both have recovered. MD office not notified of symptoms until 1-9-17.
Neck and back pain; Neck and back pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Neck and back pain) and BACK PAIN (Neck and back pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck and back pain) and BACK PAIN (Neck and back pain). On 28-Mar-2021, NECK PAIN (Neck and back pain) and BACK PAIN (Neck and back pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medication was reported. Treatment information was not provided. Patient does not want to take the second shot due to the side effects she experienced with the first shot. She also confirmed with her  HCP about it.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12-May-2021 contains non-significant information.
Moderna Vaccine under age 18; Inappropriate schedule of vaccine administered; Maternal exposure during pregnancy.; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine under age 18), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy.) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050E21A and 052E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 13-Mar-2021 and the estimated date of delivery was 24-Dec-2021. On 19-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine under age 18), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy.). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy.  On 19-Sep-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy.) had resolved. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine under age 18) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, Pregnancy test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported. Treatment information was not provided  This case concerns a 17-year-old female patient with no relevant medical history, who experienced the unexpected events of maternal exposure during pregnancy and inappropriate age at vaccine administration with no associated AEs. The patient received the first dose of mRNA-1273 at approximately 21 weeks of pregnancy, and second dose at approximately 27 weeks. Rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 COVID-19 Vaccine in not affected by this report   This case was linked to MOD-2021-283972 (Patient Link). Sender's Comments: This case concerns a 17-year-old female patient with no relevant medical history, who experienced the unexpected events of maternal exposure during pregnancy and inappropriate age at vaccine administration with no associated AEs. The patient received the first dose of mRNA-1273 at approximately 21 weeks of pregnancy, and second dose at approximately 27 weeks. Rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 COVID-19 Vaccine in not affected by this report
headaches; she felt weak; having a little bit of a temperature; had to ice arm because it felt swollen and painful; had to ice arm because it felt swollen and painful; sweating; felt hot; This is a spontaneous report from a contactable consumer reported for herself. A 42-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 16Aug2021 (at the age 42-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. On 16Aug2021 (Monday), having headaches after injection of Pfizer covid-19 vaccine. On Monday, when patient got it, patient felt weak. Patient read the paper they gave her that said it was normal and little bit of a temperature, but that was fine. Yesterday, patient felt really weak, had headaches, and had to ice arm because it felt swollen and painful. The headaches come and go. This morning, patient could not even get out of bed; felt really weak. Describes headache as the top portion of it (her head) was pulsating, hurting. States this was too much. Patient was tearful. States that patient knows it was part of the side effects, but thought it was more with the second dose. Patient works in front of computer, but can't with this. Patient was trying to clean up a little bit, but was sweating like crazy. Patient told her son it felt hot, he said its not hot. Patient was supposed to go back to work yesterday and today, but could not. Asked what patient should do, keep taking Tylenol. The outcome of the event pyrexia was unknown while other events were not recovered.   The lot number was not provided. Information on lot number has been requested during follow up.
Low fever, chills, muscle aches, headache, nausea, sore injection site, fatigue/exhaustion. Bad for 12 hours, milder for 12 hours. 24 hours total. Symptoms started 8 hours after injection.
My throat felt as if it was closing so, I took a BENADRYL at 3:30 am and went back to sleep. Later that morning 9:30 am a rash started on my face and arms. I phoned my doctor who advised me to come in ASAP. He prescribed: "Prednisone and Famotidine" the itching continued for more than 1 weeks, but I have since recovered.
2 Patients received 0.5 mL third dose and were not immunocompromised/received the third dose about 10 days ago; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (2 Patients received 0.5 mL third dose and were not immunocompromised/received the third dose about 10 days ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (2 Patients received 0.5 mL third dose and were not immunocompromised/received the third dose about 10 days ago). On 15-Oct-2021, ACCIDENTAL OVERDOSE (2 Patients received 0.5 mL third dose and were not immunocompromised/received the third dose about 10 days ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.  They patients who claimed being immunocompromised received a full dose of 0.5 mL dose, but then came back concerned because the approved dosage for booster was 0.25 mL and they were not actually immunocompromised. The reporter informed that the patients received the third dose about 10 days ago. The reporter followed up with patients and they said they were fine.
More tired than usual; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 15Apr2021 at 15:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Other medical history included depression and penicillin allergy. The patient had drug allergies to doxycycline, ultram, codeine, prilosec; all on an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included potassium (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), diclofenac (VOLTAREN) and carvedilol (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 09:00, the patient was more tired than usual. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event more tired than usual was recovered on 16Apr2021.   No follow-up attempts are needed. No further information is expected.
The patient had mild lip swelling, and tongue felt funny 15 to 20 minutes after their 1st dose. The patient was asked to sit for a few minutes longer to monitor but said they were okay and went home. It was recommended to have Benadryl on hand in case they needed it, and if any of his symptoms worsened at all to go to the hospital.  I called and followed up with patient 1 & 1/2 hour after his shot and he was feeling much better and had taken a dose of Benadryl. He was again advised to monitor for any more signs or symptoms of lip/tongue/throat swelling and to seek medical attention if was having any of these symptoms. He also was advised to follow up with his PCP to see if he should get his 2nd dose or hold off due to the reaction he experienced.
Info has been received from a physician concerning a male pt who was vaccinated with a 2nd dose of pneumococcal vaccine 23 polyvalent. Subsequently, the pt experienced urticaria when he was revaccinated 7 years after the 1st dose. Unspecified medical attention was sought. At the time of the report, the outcome was unknown. Additional info has been requested.
Expired vaccine used-11 days after opening; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used-11 days after opening) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used-11 days after opening). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used-11 days after opening) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported by the reporter Treatment drugs were not reported by the reporter Vial was punctured 11 days before administration.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information was received include no new information.
Mild headache and fever ranging from 100-102.75 degrees Fahrenheit over the course of 2 days. Took Tylenol and drank a lot of liquids to ease fever.
Swollen under left arm in armpit, slightly painful, pain radiates outward from swollen site
?suspect pertussis react; t104.9, cough; 12MAY dx pneumonia, LOM; tx w/Rocephin, Augmentin;
Shingles rash; This case was reported by a pharmacist via call center representative and described the occurrence of vesicular rash in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number GX25K, expiry date 19th November 2021) for prophylaxis.   On 1st July 2019, the patient received the 1st dose of Shingrix .5 ml. In July 2019, 1 day after receiving Shingrix, the patient experienced vesicular rash. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the vesicular rash was not recovered/not resolved.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.  Additional details were provided as follows: A day or two later receiving Shingrix, the shingles rash was presented on the patient's truck and down his arm on the right side. He was treated at a walk in clinic and given steroids. The reporter consented to follow up. There is a discrepancy between the outcome reported in the structured field (not recovered) and the outcome reported in the source document (recovering).
MIXING YELLOW FEVER VACCINE  WITH WRONG DILUENT (STERILE WATER DILUENT BY MERCK) AND ADMINISTERED TO PATIENT AT 3:40 PM ON 07/22/2023 AND REPEATED THE DOSE AT 7:00 PM ON THE SAME DAY. PATIENT TRAVEL DATES 08/05/2023 - 07/13/2023. PATIENT HAS NO SIGNS OF ADVERSE REACTION AT THIS TIME
Red spot, rash (?) on face, neck and swollen (started 2012 and 2013 not seriously).
at 11:00 P.M. I went to sleep after receiving my shot and I had severe pounding in my chest. I took 2 Alprazolan .25 before it stopped. Iwas just aout ready to go to the hospital but it did stop.  Then on on 3/9 I had pain in my left hip area. I looked and my upper thigh had a sever rash with what appeared to be welts .  This lasted for about 1 week
17 year old patient was incorrectly given the first dose of Moderna COVID vaccine today secondary to inaccurate ID check. Patient was counseled about the error. Patient completed 15 minutes of monitoring onsite without any adverse effects.
From day one pain in arm (L) and cannot bend without pain. Not red or swollen. Patient states hurt when went in. Be definitely seeking treatment.
97/47, HR 70, c/o lightheadedness.  Pt. received vaccine via RD started getting pale and stated felt faint.  Pt. lowered in passenger front seat.  Fire Rescue called, checked vitals.  Pt. stated feeling better.  Sat back up in seat, sipped water.  Pt. stable.  No acute distress noted.
Patient reports feeling "sick and drained (Tired)".  Also reports redness at site and a hard knot at the injection site.  It has been a week.
Red inflamed skin from shoulder down to elbow on left arm warm to touch. Slight rash under skin extreme itching.
Patients arm was swollen,she also had arm pain,fever,chills nausea,and headache.  Her MD said she probably had already been previously exposed to a bug.  She is getting better
Wanted to report additional side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Wanted to report additional side effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Wanted to report additional side effect). At the time of the report, VACCINATION COMPLICATION (Wanted to report additional side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-APR-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 136 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 40 hours with the lowest recorded temperature of 34 Fahrenheit degree.  The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
2 weeks after the second dose i started having heart palpitations. I did not do anything at first, by april 4th i was having them multiple times a day every day. I went for an ekg and they found a palpitation. I followed up with my doctor and we ran more tests like and echo and halter monitor but could not find anything.  At this point i was up to 40+ palpitations a day. The halter monitor could not see it though. She started treatment with Propanolol 20 mg twice a day for six weeks. Over the course of 6 weeks it slowly went away. on the final week I was finally down to 0 palpitations for 3 consecutive days. The meds ended and a couple days later they started coming back. up to about ten times a day. Then slowly faded out and went away. Around this time I saw articles for Heart Inflammation for Phizer. My timeline and age fit close to the brackets and fit the timeline so wanted to report it.
a potential reaction to surgical adhesive; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 02Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date of 2021, after the first dose, patient had gall bladder surgery and had a potential reaction to the oxycodone and surgical adhesive. Patient asked that if it was okay to take the vaccine, as she was scheduled to receive the second dose tomorrow (24Feb2021). The outcome of the event was unknown.  Information on lot/ batch number has been requested.  Follow-up attempts are completed. No further information is expected.   No follow-up attempts are completed; information about lot/batch number cannot be obtained.
pt recv vax & devel a fever between 103-104 8-9 days p/vax;3 other children were given the same lot# & exp t103-104; pt also exp dec appetite;